ライフサイエンスコーパス: anal verge

1 abdominal posterior dissection to <4 cm from anal verge.

2 e distal rectum, approximately 5 cm from the anal verge.

3 ts with adenocarcinoma 6 cm or less from the anal verge.

4 ctal adenocarcinoma less than 15 cm from the anal verge.

5 and had a tumour located within 15 cm of the anal verge.

6 umors were located a median of 5 cm from the anal verge.

7 on OC are located behind a fold or near the anal verge.

8 after adjustment for tumor distance from the anal verge.

9 tal lesions were located within 10 cm of the anal verge.

10 ormal-appearing rectal mucosa 10 cm from the anal verge.

11 ally confirmed T3 lesions within 8 cm of the anal verge.

12 stance of 6.7 cm (range, 0-15.0 cm) from the anal verge.

13 s in the OPRA trial had tumors closer to the anal verge.

14 astomotic height was 3.5 +/- 1.9 cm from the anal verge.

15 ith reanastomosis of "normal" bowel near the anal verge.

16 distal tumour border of less than 12 cm from anal verge.

17 stoma, neoadjuvant treatment, distance from anal verge, anastomotic leak) were collected.

18 atified according to tumor distance from the anal verge and neoadjuvant treatment given and randomize

19 nduced apoptosis, measured at 20 cm from the anal verge, and colon cancer risk.

20 of positive lymph nodes, tumor distance from anal verge, and large- and small-vessel venous and perin

21 nse, tumor location of 5 cm or less from the anal verge, and neurovascular invasion.

22 ce of the rectum, located within 8 cm of the anal verge, and with an Eastern Cooperative Oncology Gro

23 umor characteristics (mean distance from the anal verge, annularity, fixation).

24 I LARC with distal location (cT3-4 5 cm from anal verge, any N), with bulky disease (any cT4 or tumor

25 roup, 52 (40%) of tumors were <5 cm from the anal verge (AV); in the TEMS group, only 1 (2%) (P = 0.0

26 ignificant variation in the IO distance from anal verge between fistulas in the different anal quadra

27 adenocarcinomas of the rectum (0-15 cm from anal verge) by either transanal excision (TAE) or radica

28 ak were anastomoses less than 10 cm from the anal verge, CCI of 3 or more, high inferior mesenteric a

29 d, and biopsies were taken at 20 cm from the anal verge, cecum, and descending colon.

30 neoadjuvant therapy, distance of tumor from anal verge, defunctioning stoma, and pathologic stage, c

31 th T3 rectal cancers less than 8 cm from the anal verge, even if the surgery includes a properly perf

32 rectal cancer located within 15 cm from the anal verge, followed by surgery.

33 istal colon (2, 6, 8, 16, and 24 mm from the anal verge) from normal and Ls/Ls mice (mice homozygous

34 h T1 to T3 rectal adenocarcinoma <15 cm from anal verge, given Lap or Open and followed for a minimum

35 es, patients with a tumour 10-15 cm from the anal verge had improved disease-free survival (0.59, 0.4

36 rt length, and small distance of IO from the anal verge improve surgical outcomes and decrease compli

37 The IO was 11-20 mm above the anal verge in 58.5% of fistulas and <= 10 mm in 27.4%.

38 fit patients with a tumour 10-15 cm from the anal verge in terms of disease-free survival and distant

39 ly in distally located tumors (distance from anal verge <5 cm) (P = 0.03).

40 owing: pathologic stage, tumor distance from anal verge, lymphovascular or perineural invasion.

41 ients with very low tumors (</=4 cm from the anal verge), no significant difference in the local recu

42 ocarcinoma of the rectum within 15 cm of the anal verge, not invading adjacent tissues, and without d

43 ctal cancer, with a median distance from the anal verge of 5.0 cm.

44 sis of a rectal tumor 15 cm or less from the anal verge on magnetic resonance imaging were eligible f

45 ere: 1 cm decrease in tumor height above the anal verge (OR = 1.290, 95% CI: 1.101,1.511); and an ASA

46 , 1.5-9.6), tumors less than 4.0 cm from the anal verge (OR = 3.4; 95% CI, 1.3-8.8), and anterior tum

47 Age, sex, tumor distance from the anal verge, pathological tumor classification, and clini

48 umor is palpated approximately 3 cm from the anal verge, posterior and slightly to the right, positio

49 cinoma at a median distance of 6 cm from the anal verge (range 0-15 cm) were treated with preoperativ

50 , located a median distance of 7 cm from the anal verge, requiring preoperative CMT, and undergoing a

51 ents with low rectal cancer (< 6 cm from the anal verge) suitable for sphincter preservation were ran

52 ge II/III rectal cancer, within 12 cm of the anal verge (T1-3, N0-2, M0) in patients who received neo

53 rectal adenocarcinoma within 12 cm from the anal verge, T3/4 and/or node positive, were randomly ass

54 ariate analysis, the tumor distance from the anal verge, the resection margin status, the T stage, an

55 T3-4 and/or uN1) located < or =6 cm from the anal verge, treated by preoperative chemoradiation and t

56 Median anastomotic height from anal verge was 3.0 +/- 2.0 cm with stapled techniques ac

57 Mean tumor distance from the anal verge was 6 cm (range 1-15).

58 Mucosal biopsies from 15 to 20 cm from the anal verge were incubated in 1 mM sodium deoxycholate, a

59 II or III rectal cancer within 12 cm of the anal verge were randomized after completion of neoadjuva

60 A]; and disease extending 25 cm or more from anal verge) were randomised (1:1:1) to one of two dose l

61 10) for rectal adenocarcinoma (</=15 cm from anal verge) were retrospectively analyzed using a prospe

62 e bulk of the lesion is below 15 cm from the anal verge, will be randomised between either a TAMIS or

63 body mass index, and tumor distance from the anal verge with match ratio 1:4. Functional outcomes wer

64 T3 rectal adenocarcinoma within 12 cm of the anal verge with no evidence of metastasis.

65 colitis extending more than 15 cm beyond the anal verge (with a total Mayo score >/=6 and a Mayo endo